Fny Investment Advisers, LLC Grifols Sa Transaction History

Fny Investment Advisers, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$10.6 - $13.28 $106,000 - $132,800	-10,000 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$10.37 - $12.73 $103,699 - $127,300	10,000 New	10,000 $116,000
Q4 2021 Jan 10, 2022	SELL	$10.21 - $15.27 $296,283 - $443,120	-29,019 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$14.07 - $17.3 $321,063 - $394,768	22,819 Added 368.05%	29,019 $423,000
Q2 2021 Jul 14, 2021	BUY	$16.62 - $18.94 $103,044 - $117,428	6,200 New	6,200 $107,000
Q1 2021 Apr 12, 2021	SELL	$15.15 - $19.78 $1.15 Million - $1.51 Million	-76,159 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$16.86 - $19.67 $238,585 - $278,350	-14,151 Reduced 15.67%	76,159 $1.4 Million
Q3 2020 Oct 09, 2020	BUY	$15.4 - $20.16 $1.39 Million - $1.82 Million	90,310 New	90,310 $1.57 Million
Q1 2019 Apr 17, 2019	SELL	$18.01 - $20.11 $1.67 Million - $1.86 Million	-92,500 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$17.44 - $21.53 $1.61 Million - $1.99 Million	92,500 New	92,500 $1.7 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.1B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.